APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Eltrombopag Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Eltrombopag Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025198 pages

Choose your research edition.

Industry ResearchEltrombopag Drugs Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Eltrombopag Drugs Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Eltrombopag Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Eltrombopag Drugs Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Eltrombopag Drugs Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Eltrombopag Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Eltrombopag Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Eltrombopag Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Eltrombopag Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Eltrombopag Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Eltrombopag Drugs include Actavis Laboratories, Amneal Pharmaceuticals, Annora Pharma, Hetero, Novartis, Teva, Changzhou Pharmaceutical Factory, Guangdong Longfu Pharmaceutical and Ningbo Menovo Tiankang Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Eltrombopag Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Eltrombopag Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Eltrombopag Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Eltrombopag Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Eltrombopag Drugs Segment by Company

Actavis Laboratories

Amneal Pharmaceuticals

Annora Pharma

Hetero

Novartis

Teva

Changzhou Pharmaceutical Factory

Guangdong Longfu Pharmaceutical

Ningbo Menovo Tiankang Pharmaceutical

Qilu Pharmaceutical

Shandong Jewim Pharmaceutical

Sichuan Kelun Pharmaceutical

Grand Pharmaceutical

Zhejiang Hisun Pharmaceutical

Chia Tai Tianqing Pharmaceutical

Eltrombopag Drugs Segment by Type

Tablets

Oral Suspension

Eltrombopag Drugs Segment by Application

Hospital and Clinic

Pharmacy

Other

Eltrombopag Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Eltrombopag Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Eltrombopag Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Eltrombopag Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Eltrombopag Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Eltrombopag Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Eltrombopag Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Eltrombopag Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Eltrombopag Drugs Industry Trends Table 2. Eltrombopag Drugs Industry Drivers Table 3. Eltrombopag Drugs Industry Opportunities and Challenges Table 4. Eltrombopag Drugs Industry Restraints Table 5. Global Eltrombopag Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Eltrombopag Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Eltrombopag Drugs Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Eltrombopag Drugs Sales Market Share by Manufacturers Table 9. Global Eltrombopag Drugs Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Eltrombopag Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Eltrombopag Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Eltrombopag Drugs Manufacturers, Product Type & Application Table 13. Global Eltrombopag Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Eltrombopag Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Tablets Table 17. Major Manufacturers of Oral Suspension Table 18. Global Eltrombopag Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Eltrombopag Drugs Sales by Type (2021-2026) & (K Units) Table 20. Global Eltrombopag Drugs Sales by Type (2027-2032) & (K Units) Table 21. Global Eltrombopag Drugs Sales Market Share by Type (2021-2026) Table 22. Global Eltrombopag Drugs Sales Market Share by Type (2027-2032) Table 23. Global Eltrombopag Drugs Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Eltrombopag Drugs Revenue by Type (2021-2026) & (K Units) Table 25. Global Eltrombopag Drugs Revenue by Type (2027-2032) & (K Units) Table 26. Global Eltrombopag Drugs Revenue Market Share by Type (2021-2026) Table 27. Global Eltrombopag Drugs Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital and Clinic Table 29. Major Manufacturers of Pharmacy Table 30. Major Manufacturers of Other Table 31. Global Eltrombopag Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Eltrombopag Drugs Sales by Application (2021-2026) & (K Units) Table 33. Global Eltrombopag Drugs Sales by Application (2027-2032) & (K Units) Table 34. Global Eltrombopag Drugs Sales Market Share by Application (2021-2026) Table 35. Global Eltrombopag Drugs Sales Market Share by Application (2027-2032) Table 36. Global Eltrombopag Drugs Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Eltrombopag Drugs Revenue by Application (2021-2026) & (K Units) Table 38. Global Eltrombopag Drugs Revenue by Application (2027-2032) & (K Units) Table 39. Global Eltrombopag Drugs Revenue Market Share by Application (2021-2026) Table 40. Global Eltrombopag Drugs Revenue Market Share by Application (2027-2032) Table 41. Global Eltrombopag Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Eltrombopag Drugs Sales by Region (2021-2026) & (K Units) Table 43. Global Eltrombopag Drugs Sales Market Share by Region (2021-2026) Table 44. Global Eltrombopag Drugs Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Eltrombopag Drugs Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Eltrombopag Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Eltrombopag Drugs Sales by Country (2021-2026) & (K Units) Table 48. North America Eltrombopag Drugs Sales by Country (2027-2032) & (K Units) Table 49. Europe Eltrombopag Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Eltrombopag Drugs Sales by Country (2021-2026) & (K Units) Table 51. Europe Eltrombopag Drugs Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Eltrombopag Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Eltrombopag Drugs Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Eltrombopag Drugs Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Eltrombopag Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Eltrombopag Drugs Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Eltrombopag Drugs Sales by Country (2027-2032) & (K Units) Table 58. Global Eltrombopag Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Eltrombopag Drugs Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Eltrombopag Drugs Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Eltrombopag Drugs Revenue Market Share by Region (2021-2026) Table 62. Global Eltrombopag Drugs Revenue Market Share by Region (2027-2032) Table 63. Actavis Laboratories Company Information Table 64. Actavis Laboratories Business Overview Table 65. Actavis Laboratories Eltrombopag Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Actavis Laboratories Eltrombopag Drugs Product Portfolio Table 67. Actavis Laboratories Recent Development Table 68. Amneal Pharmaceuticals Company Information Table 69. Amneal Pharmaceuticals Business Overview Table 70. Amneal Pharmaceuticals Eltrombopag Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Amneal Pharmaceuticals Eltrombopag Drugs Product Portfolio Table 72. Amneal Pharmaceuticals Recent Development Table 73. Annora Pharma Company Information Table 74. Annora Pharma Business Overview Table 75. Annora Pharma Eltrombopag Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Annora Pharma Eltrombopag Drugs Product Portfolio Table 77. Annora Pharma Recent Development Table 78. Hetero Company Information Table 79. Hetero Business Overview Table 80. Hetero Eltrombopag Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Hetero Eltrombopag Drugs Product Portfolio Table 82. Hetero Recent Development Table 83. Novartis Company Information Table 84. Novartis Business Overview Table 85. Novartis Eltrombopag Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Novartis Eltrombopag Drugs Product Portfolio Table 87. Novartis Recent Development Table 88. Teva Company Information Table 89. Teva Business Overview Table 90. Teva Eltrombopag Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Teva Eltrombopag Drugs Product Portfolio Table 92. Teva Recent Development Table 93. Changzhou Pharmaceutical Factory Company Information Table 94. Changzhou Pharmaceutical Factory Business Overview Table 95. Changzhou Pharmaceutical Factory Eltrombopag Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Changzhou Pharmaceutical Factory Eltrombopag Drugs Product Portfolio Table 97. Changzhou Pharmaceutical Factory Recent Development Table 98. Guangdong Longfu Pharmaceutical Company Information Table 99. Guangdong Longfu Pharmaceutical Business Overview Table 100. Guangdong Longfu Pharmaceutical Eltrombopag Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Guangdong Longfu Pharmaceutical Eltrombopag Drugs Product Portfolio Table 102. Guangdong Longfu Pharmaceutical Recent Development Table 103. Ningbo Menovo Tiankang Pharmaceutical Company Information Table 104. Ningbo Menovo Tiankang Pharmaceutical Business Overview Table 105. Ningbo Menovo Tiankang Pharmaceutical Eltrombopag Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Ningbo Menovo Tiankang Pharmaceutical Eltrombopag Drugs Product Portfolio Table 107. Ningbo Menovo Tiankang Pharmaceutical Recent Development Table 108. Qilu Pharmaceutical Company Information Table 109. Qilu Pharmaceutical Business Overview Table 110. Qilu Pharmaceutical Eltrombopag Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Qilu Pharmaceutical Eltrombopag Drugs Product Portfolio Table 112. Qilu Pharmaceutical Recent Development Table 113. Shandong Jewim Pharmaceutical Company Information Table 114. Shandong Jewim Pharmaceutical Business Overview Table 115. Shandong Jewim Pharmaceutical Eltrombopag Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Shandong Jewim Pharmaceutical Eltrombopag Drugs Product Portfolio Table 117. Shandong Jewim Pharmaceutical Recent Development Table 118. Sichuan Kelun Pharmaceutical Company Information Table 119. Sichuan Kelun Pharmaceutical Business Overview Table 120. Sichuan Kelun Pharmaceutical Eltrombopag Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Sichuan Kelun Pharmaceutical Eltrombopag Drugs Product Portfolio Table 122. Sichuan Kelun Pharmaceutical Recent Development Table 123. Grand Pharmaceutical Company Information Table 124. Grand Pharmaceutical Business Overview Table 125. Grand Pharmaceutical Eltrombopag Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Grand Pharmaceutical Eltrombopag Drugs Product Portfolio Table 127. Grand Pharmaceutical Recent Development Table 128. Zhejiang Hisun Pharmaceutical Company Information Table 129. Zhejiang Hisun Pharmaceutical Business Overview Table 130. Zhejiang Hisun Pharmaceutical Eltrombopag Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Zhejiang Hisun Pharmaceutical Eltrombopag Drugs Product Portfolio Table 132. Zhejiang Hisun Pharmaceutical Recent Development Table 133. Chia Tai Tianqing Pharmaceutical Company Information Table 134. Chia Tai Tianqing Pharmaceutical Business Overview Table 135. Chia Tai Tianqing Pharmaceutical Eltrombopag Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Chia Tai Tianqing Pharmaceutical Eltrombopag Drugs Product Portfolio Table 137. Chia Tai Tianqing Pharmaceutical Recent Development Table 138. Key Raw Materials Table 139. Raw Materials Key Suppliers Table 140. Eltrombopag Drugs Distributors List Table 141. Eltrombopag Drugs Customers List Table 142. Research Programs/Design for This Report Table 143. Authors List of This Report Table 144. Secondary Sources Table 145. Primary Sources List of Figures Figure 1. Eltrombopag Drugs Product Image Figure 2. Global Eltrombopag Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Eltrombopag Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Eltrombopag Drugs Sales (2021-2032) & (K Units) Figure 5. Global Eltrombopag Drugs Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Eltrombopag Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Tablets Image Figure 9. Oral Suspension Image Figure 10. Global Eltrombopag Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Eltrombopag Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Eltrombopag Drugs Sales Market Share by Type (2021-2032) Figure 13. Global Eltrombopag Drugs Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Eltrombopag Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Eltrombopag Drugs Revenue Market Share by Type (2021-2032) Figure 16. Hospital and Clinic Image Figure 17. Pharmacy Image Figure 18. Other Image Figure 19. Global Eltrombopag Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Eltrombopag Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Eltrombopag Drugs Sales Market Share by Application (2021-2032) Figure 22. Global Eltrombopag Drugs Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Eltrombopag Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Eltrombopag Drugs Revenue Market Share by Application (2021-2032) Figure 25. North America Eltrombopag Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Eltrombopag Drugs Sales Market Share by Country (2021-2032) Figure 27. U.S. Eltrombopag Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Eltrombopag Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Eltrombopag Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Eltrombopag Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Eltrombopag Drugs Sales Market Share by Country (2021-2032) Figure 32. Germany Eltrombopag Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Eltrombopag Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Eltrombopag Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Eltrombopag Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Eltrombopag Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Eltrombopag Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Eltrombopag Drugs Sales Market Share by Country (2021-2032) Figure 39. China Eltrombopag Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Eltrombopag Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Eltrombopag Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Eltrombopag Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Eltrombopag Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Eltrombopag Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Eltrombopag Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Eltrombopag Drugs Sales Market Share by Country (2021-2032) Figure 47. Brazil Eltrombopag Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Eltrombopag Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Eltrombopag Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Eltrombopag Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Eltrombopag Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Eltrombopag Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Eltrombopag Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Eltrombopag Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Eltrombopag Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Eltrombopag Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Eltrombopag Drugs Revenue (2021-2032) & (US$ Million) Figure 58. North America Eltrombopag Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Eltrombopag Drugs Revenue (2021-2032) & (US$ Million) Figure 60. Europe Eltrombopag Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Eltrombopag Drugs Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Eltrombopag Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Eltrombopag Drugs Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Eltrombopag Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Eltrombopag Drugs Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Eltrombopag Drugs Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Tablets
  • Oral Suspension
Applications
  • Hospital and Clinic
  • Pharmacy
  • Other
Companies covered
  • Actavis Laboratories
  • Amneal Pharmaceuticals
  • Annora Pharma
  • Hetero
  • Novartis
  • Teva
  • Changzhou Pharmaceutical Factory
  • Guangdong Longfu Pharmaceutical
  • Ningbo Menovo Tiankang Pharmaceutical
  • Qilu Pharmaceutical
  • Shandong Jewim Pharmaceutical
  • Sichuan Kelun Pharmaceutical
  • Grand Pharmaceutical
  • Zhejiang Hisun Pharmaceutical
  • Chia Tai Tianqing Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Eltrombopag Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Eltrombopag Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Eltrombopag Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Eltrombopag Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Eltrombopag Drugs Market Dynamics
  1. 2.1 Eltrombopag Drugs Industry Trends
  2. 2.2 Eltrombopag Drugs Industry Drivers
  3. 2.3 Eltrombopag Drugs Industry Opportunities and Challenges
  4. 2.4 Eltrombopag Drugs Industry Restraints
3 Eltrombopag Drugs Market by Manufacturers
  1. 3.1 Global Eltrombopag Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Eltrombopag Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Eltrombopag Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Eltrombopag Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Eltrombopag Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Eltrombopag Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Eltrombopag Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Eltrombopag Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Eltrombopag Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Eltrombopag Drugs Tier 1, Tier 2, and Tier 3
4 Eltrombopag Drugs Market by Type
  1. 4.1 Eltrombopag Drugs Type Introduction
  2. 4.1.1 Tablets
  3. 4.1.2 Oral Suspension
  4. 4.2 Global Eltrombopag Drugs Sales by Type
  5. 4.2.1 Global Eltrombopag Drugs Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Eltrombopag Drugs Sales by Type (2021-2032)
  7. 4.2.3 Global Eltrombopag Drugs Sales Market Share by Type (2021-2032)
  8. 4.3 Global Eltrombopag Drugs Revenue by Type
  9. 4.3.1 Global Eltrombopag Drugs Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Eltrombopag Drugs Revenue by Type (2021-2032)
  11. 4.3.3 Global Eltrombopag Drugs Revenue Market Share by Type (2021-2032)
5 Eltrombopag Drugs Market by Application
  1. 5.1 Eltrombopag Drugs Application Introduction
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Pharmacy
  4. 5.1.3 Other
  5. 5.2 Global Eltrombopag Drugs Sales by Application
  6. 5.2.1 Global Eltrombopag Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Eltrombopag Drugs Sales by Application (2021-2032)
  8. 5.2.3 Global Eltrombopag Drugs Sales Market Share by Application (2021-2032)
  9. 5.3 Global Eltrombopag Drugs Revenue by Application
  10. 5.3.1 Global Eltrombopag Drugs Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Eltrombopag Drugs Revenue by Application (2021-2032)
  12. 5.3.3 Global Eltrombopag Drugs Revenue Market Share by Application (2021-2032)
6 Global Eltrombopag Drugs Sales by Region
  1. 6.1 Global Eltrombopag Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Eltrombopag Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Eltrombopag Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Eltrombopag Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Eltrombopag Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Eltrombopag Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Eltrombopag Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Eltrombopag Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Eltrombopag Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Eltrombopag Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Eltrombopag Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Eltrombopag Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Eltrombopag Drugs Revenue by Region
  1. 7.1 Global Eltrombopag Drugs Revenue by Region
  2. 7.1.1 Global Eltrombopag Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Eltrombopag Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Eltrombopag Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Eltrombopag Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Eltrombopag Drugs Revenue (2021-2032)
  8. 7.2.2 North America Eltrombopag Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Eltrombopag Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Eltrombopag Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Eltrombopag Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Eltrombopag Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Eltrombopag Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Eltrombopag Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Actavis Laboratories
  2. 8.1.1 Actavis Laboratories Company Information
  3. 8.1.2 Actavis Laboratories Business Overview
  4. 8.1.3 Actavis Laboratories Eltrombopag Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Actavis Laboratories Eltrombopag Drugs Product Portfolio
  6. 8.1.5 Actavis Laboratories Recent Developments
  7. 8.2 Amneal Pharmaceuticals
  8. 8.2.1 Amneal Pharmaceuticals Company Information
  9. 8.2.2 Amneal Pharmaceuticals Business Overview
  10. 8.2.3 Amneal Pharmaceuticals Eltrombopag Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Amneal Pharmaceuticals Eltrombopag Drugs Product Portfolio
  12. 8.2.5 Amneal Pharmaceuticals Recent Developments
  13. 8.3 Annora Pharma
  14. 8.3.1 Annora Pharma Company Information
  15. 8.3.2 Annora Pharma Business Overview
  16. 8.3.3 Annora Pharma Eltrombopag Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Annora Pharma Eltrombopag Drugs Product Portfolio
  18. 8.3.5 Annora Pharma Recent Developments
  19. 8.4 Hetero
  20. 8.4.1 Hetero Company Information
  21. 8.4.2 Hetero Business Overview
  22. 8.4.3 Hetero Eltrombopag Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Hetero Eltrombopag Drugs Product Portfolio
  24. 8.4.5 Hetero Recent Developments
  25. 8.5 Novartis
  26. 8.5.1 Novartis Company Information
  27. 8.5.2 Novartis Business Overview
  28. 8.5.3 Novartis Eltrombopag Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Novartis Eltrombopag Drugs Product Portfolio
  30. 8.5.5 Novartis Recent Developments
  31. 8.6 Teva
  32. 8.6.1 Teva Company Information
  33. 8.6.2 Teva Business Overview
  34. 8.6.3 Teva Eltrombopag Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Teva Eltrombopag Drugs Product Portfolio
  36. 8.6.5 Teva Recent Developments
  37. 8.7 Changzhou Pharmaceutical Factory
  38. 8.7.1 Changzhou Pharmaceutical Factory Company Information
  39. 8.7.2 Changzhou Pharmaceutical Factory Business Overview
  40. 8.7.3 Changzhou Pharmaceutical Factory Eltrombopag Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Changzhou Pharmaceutical Factory Eltrombopag Drugs Product Portfolio
  42. 8.7.5 Changzhou Pharmaceutical Factory Recent Developments
  43. 8.8 Guangdong Longfu Pharmaceutical
  44. 8.8.1 Guangdong Longfu Pharmaceutical Company Information
  45. 8.8.2 Guangdong Longfu Pharmaceutical Business Overview
  46. 8.8.3 Guangdong Longfu Pharmaceutical Eltrombopag Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Guangdong Longfu Pharmaceutical Eltrombopag Drugs Product Portfolio
  48. 8.8.5 Guangdong Longfu Pharmaceutical Recent Developments
  49. 8.9 Ningbo Menovo Tiankang Pharmaceutical
  50. 8.9.1 Ningbo Menovo Tiankang Pharmaceutical Company Information
  51. 8.9.2 Ningbo Menovo Tiankang Pharmaceutical Business Overview
  52. 8.9.3 Ningbo Menovo Tiankang Pharmaceutical Eltrombopag Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Ningbo Menovo Tiankang Pharmaceutical Eltrombopag Drugs Product Portfolio
  54. 8.9.5 Ningbo Menovo Tiankang Pharmaceutical Recent Developments
  55. 8.10 Qilu Pharmaceutical
  56. 8.10.1 Qilu Pharmaceutical Company Information
  57. 8.10.2 Qilu Pharmaceutical Business Overview
  58. 8.10.3 Qilu Pharmaceutical Eltrombopag Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Qilu Pharmaceutical Eltrombopag Drugs Product Portfolio
  60. 8.10.5 Qilu Pharmaceutical Recent Developments
  61. 8.11 Shandong Jewim Pharmaceutical
  62. 8.11.1 Shandong Jewim Pharmaceutical Company Information
  63. 8.11.2 Shandong Jewim Pharmaceutical Business Overview
  64. 8.11.3 Shandong Jewim Pharmaceutical Eltrombopag Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Shandong Jewim Pharmaceutical Eltrombopag Drugs Product Portfolio
  66. 8.11.5 Shandong Jewim Pharmaceutical Recent Developments
  67. 8.12 Sichuan Kelun Pharmaceutical
  68. 8.12.1 Sichuan Kelun Pharmaceutical Company Information
  69. 8.12.2 Sichuan Kelun Pharmaceutical Business Overview
  70. 8.12.3 Sichuan Kelun Pharmaceutical Eltrombopag Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Sichuan Kelun Pharmaceutical Eltrombopag Drugs Product Portfolio
  72. 8.12.5 Sichuan Kelun Pharmaceutical Recent Developments
  73. 8.13 Grand Pharmaceutical
  74. 8.13.1 Grand Pharmaceutical Company Information
  75. 8.13.2 Grand Pharmaceutical Business Overview
  76. 8.13.3 Grand Pharmaceutical Eltrombopag Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Grand Pharmaceutical Eltrombopag Drugs Product Portfolio
  78. 8.13.5 Grand Pharmaceutical Recent Developments
  79. 8.14 Zhejiang Hisun Pharmaceutical
  80. 8.14.1 Zhejiang Hisun Pharmaceutical Company Information
  81. 8.14.2 Zhejiang Hisun Pharmaceutical Business Overview
  82. 8.14.3 Zhejiang Hisun Pharmaceutical Eltrombopag Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Zhejiang Hisun Pharmaceutical Eltrombopag Drugs Product Portfolio
  84. 8.14.5 Zhejiang Hisun Pharmaceutical Recent Developments
  85. 8.15 Chia Tai Tianqing Pharmaceutical
  86. 8.15.1 Chia Tai Tianqing Pharmaceutical Company Information
  87. 8.15.2 Chia Tai Tianqing Pharmaceutical Business Overview
  88. 8.15.3 Chia Tai Tianqing Pharmaceutical Eltrombopag Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Chia Tai Tianqing Pharmaceutical Eltrombopag Drugs Product Portfolio
  90. 8.15.5 Chia Tai Tianqing Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Eltrombopag Drugs Value Chain Analysis
  2. 9.1.1 Eltrombopag Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Eltrombopag Drugs Production Mode & Process
  6. 9.2 Eltrombopag Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Eltrombopag Drugs Distributors
  9. 9.2.3 Eltrombopag Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst